| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > The Rise of Executive Background Checks |
|
E-Folder - The Rise of Executive Background Checks
With the recent corporate scandals of Enron and WorldCom, the popularity and necessity of executive background checks has greatl According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product y increased. In order to protect themselves from potential disasters later on, many companies are now requiring extensive invest ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in gation on prospective executives to verify their employment and educational history as well as information regarding any past wr lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ngdoings. As with any other type of pre-employment background investigations, employers need to have the appropriate disclosure here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe available. According to Federal law and the Fair Credit Reporting Act, applicants must sign and date specific disclosures regar d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ding the various types of background checks employers desire. It is important to respect the privacy of potential employees whil ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc maintaining the company’s hiring standards. Although executive-level background checks are becoming increasingly more popular, easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi there may still be some hesitation as to how far to take them. Many high-level executives seem to think of their atmosphere as m nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically re of a society, or ‘country-club’ feel. They may not feel comfortable about performing checks on executives and in many cases, and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ do not feel it is necessary. Human Resource managers in the executive level seem to also have some hesitations to conducting ext ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi nsive background checks. Many of them feel as if their network of peers is enough to get the information they need and may negle ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a t to further investigate a potential employee. The Wall Street Journal suggests that many top-level hiring managers may ignore t dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod e reference list provided by the would-be-executive to utilize their own connections in their past companies. Whatever the reas cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin oning behind conducting background checks, employers need to be aware of the Federal and State laws regarding such investigation tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen . Most reputable investigation firms adhere strictly to these guidelines. Using one of the top firms can save headaches in the f t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ture while being sure that the information is fair, accurate and thorough. The employers themselves, however, can obtain some in ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ormation. Educational references can be verified by contacting the academic institution, work and salary history can be obtained y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products by contacting former employers, and character references can often be sought by contacting various people who know the prospect . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ve employee. Regardless of the method used, it is certainly in the company’s best interest to know who is working for them. In t elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip e case of top-level management, an executive background check is necessary and vital to the ongoing success of the establishment tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Start Your E-Zine Right - 5 Questions to Ask Yourself before You Begin
|